Engineered albumin fusion extends erythropoietin half-life and enables nasal delivery in mice
A human erythropoietin fused to an engineered albumin variant showed a 5.2-fold longer plasma half-life and successful intranasal delivery in ...
A human erythropoietin fused to an engineered albumin variant showed a 5.2-fold longer plasma half-life and successful intranasal delivery in ...
Researchers fused EPO to an engineered human albumin variant that binds FcRn more efficiently, extending its plasma half-life more than ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.